SPONSOR
Novo Nordisk A/S
Total Trials
7
Recruiting
7
Phases
Phase 3, Phase 1
Conditions studied: Heart FailureSystemic InflammationObesityOverweightHaemophilia AHaemophilia A With InhibitorsDiabetes Mellitus
Novo Nordisk A/S is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Heart Failure, Systemic Inflammation, Obesity, Overweight.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Novo Nordisk A/S
How many clinical trials has Novo Nordisk A/S sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Novo Nordisk A/S, of which 7 are actively recruiting participants. These trials cover conditions including Heart Failure, Systemic Inflammation, Obesity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Novo Nordisk A/S research focus on?
Novo Nordisk A/S clinical trials span Heart Failure, Systemic Inflammation, Obesity, Overweight, Haemophilia A, and additional conditions. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Novo Nordisk A/S clinical trial?
To participate in a Novo Nordisk A/S trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Novo Nordisk A/S trials with current recruitment status updated daily.
Clinical Trials by Novo Nordisk A/S
NCT05636176 Phase 3
Recruiting
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
NCT06200207 Phase 3
Recruiting
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
Heart Failure
NCT07607587 Phase 1
Recruiting
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Obesity
NCT05685238 Phase 3
Recruiting
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Haemophilia A
NCT06719011 Phase 1
Recruiting
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Obesity
NCT07533175 Phase 3
Recruiting
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Diabetes Mellitus
NCT07567001 Phase 3
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology